Skip to Main Content

Paper Details

Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS).
Clin Infect Dis
61
2022
BNT162b2, COVID, COVID-19, Coronavirus Disease 2019, HCW, HCWs, HIV, Immunocompromising Conditions, SARS-CoV, SARS-CoV-2, SOT, anti-CD20, anti-CD20 monoclonal, anti-CD20 monoclonal antibodies, autoimmune conditions, coronavirus disease, healthcare workers, hematologic malignancy, hematological malignancies, human immunodeficiency virus, immunocompromised, immunodeficiency, immunoglobulin G, mRNA-1273, messenger RNA (mRNA)-, messenger RNA (mRNA)-1273, participants, patients, persons, severe acute respiratory syndrome coronavirus, solid cancers, solid tumors
Author NameAffiliation
Fernanda P SilveiraUniversity of Pittsburgh School of Medicine
Mary E KeeblerUniversity of Pittsburgh School of Medicine
Derek C AngusUniversity of Pittsburgh Medical Center
  • 1 - 3

Datasets

Release 1.2